Which hedge funds own INO? INOVIO PHARMACEUTICALS INC, Q2 2026 13F holders
4 of the hedge funds tracked by WhaleCreep disclosed a position in INO (INOVIO PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $3.0m in total. The largest holder by portfolio weight is D. E. Shaw & Co at 0.0% of its book. 1 exited: Marshall Wace.
4tracked managers holding
0opened this quarter
1exited this quarter
Which hedge funds hold INO? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| D. E. Shaw & Co | Q2 2026 | 0.0% | $1.5m | 1,351,656 | -39% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $875.7k | 796,107 | -44% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $397.5k | 361,339 | -44% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $266.0k | 241,775 | -16% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Marshall Wace | 0.0% | $22.9k |
How has hedge fund ownership of INO changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 4 | $3.0m |
| Q1 2026 | 5 | $7.9m |
| Q4 2025 | 1 | $962.5k |
| Q3 2025 | 1 | $1.9m |
| Q2 2025 | 1 | $667.7k |
| Q1 2025 | 1 | $74.7k |
| Q4 2024 | 1 | $443.4k |
| Q3 2024 | 1 | $1.9m |
| Q2 2024 | 1 | $3.3m |
| Q1 2024 | 1 | $6.2m |
| Q4 2023 | 2 | $3.8m |
| Q3 2023 | 3 | $2.0m |
| Q2 2023 | 3 | $2.7m |
| Q1 2023 | 4 | $3.0m |
| Q4 2022 | 3 | $5.1m |
| Q3 2022 | 2 | $4.2m |
Counts every tracked manager that disclosed INO in that quarter's filing, including managers that have since stopped filing.